Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Sponsor: Beijing 302 Hospital
A PHASE4 clinical study on Liver Cirrhosis, this trial is completed. The trial is conducted by Beijing 302 Hospital and has accumulated 9 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2023 [monthly]
Completed PHASE4
-
Aug 2018 — Jan 2021 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing 302 Hospital
- Beijing Ditan Hospital
- Beijing Friendship Hospital
- Beijing Tiantan Hospital
- Beijing YouAn Hospital
- Fifth Hospital of Shijiazhuang City
- Fudan University
- Huashan Hospital
- Logistics University of Chinese People's Armed Police Forces
- Nanfang Hospital, Southern Medical University
- Peking Union Medical College Hospital
- Peking University
- Peking University First Hospital
- Peking University People's Hospital
- RenJi Hospital
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Shanghai Public Health Clinical Center
- Shanghai Zhongshan Hospital
- Sir Run Run Shaw Hospital
- Tang-Du Hospital
- The Affiliated Hospital of Yanbian University
- The First Affiliated Hospital of Shanxi Medical University
- Tongji Hospital
For direct contact, visit the study record on ClinicalTrials.gov .